Raymond James raises Fulgent Genetics stock price target to $36 on strong performance
Investing.com - Jefferies raised its price target on CSX (NASDAQ:CSX) to $40.00 from $38.00 on Monday, maintaining a Buy rating on the railroad operator’s stock. The new target represents potential upside from the current price of $35.10, aligning with the broader analyst community’s targets ranging from $27 to $43.
The price target increase comes as the transportation company shows "strong momentum" heading into the end of the year, with service levels reaching their best point in years, according to Jefferies. This momentum is reflected in CSX’s solid financial health, with InvestingPro data showing the company has maintained dividend payments for 45 consecutive years, including 20 years of consecutive increases.
Weekly volumes are accelerating due to recently announced partnerships, while infrastructure project headwinds are now "in the rear view," the firm noted in its analysis.
Jefferies views the recently announced CEO change by CSX’s Board as a move to build upon this momentum and "accelerate shareholder returns."
The firm reiterated its Buy rating on CSX stock, suggesting continued confidence in the railroad company’s growth trajectory despite the leadership transition.
In other recent news, CSX Corporation has appointed Steve Angel as its new President and CEO, effective September 28, 2025, succeeding Joe Hinrichs. This leadership change comes as RBC Capital upgraded CSX’s stock rating to Outperform, raising the price target to $39.00, citing operational improvements and strong positioning. Additionally, UBS has reiterated its Buy rating for CSX, maintaining a price target of $41.00, despite a recent decline in the stock’s value. BMO Capital has maintained its Market Perform rating with a price target of $38.00 following the CEO appointment. Steve Angel brings extensive experience, having previously served as CEO of Linde plc and Praxair. In other developments, CSX executives, including the outgoing CEO Joe Hinrichs, were scheduled to address J.P. Morgan’s U.S. All Stars Conference in London, with the presentation available via webcast. These recent developments reflect significant changes and analyst perspectives surrounding CSX Corporation.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.